Idursulfase - GC Pharma

Drug Profile

Idursulfase - GC Pharma

Alternative Names: GC 1123; GC-1111; GC1111B; Hunterase; Iduronate-2-sulfatase - GC Pharma; Idursulfase beta; Recombinant human iduronate-2-sulfatase - GC Pharma; Recombinant human iduronate-w-sulfatase

Latest Information Update: 07 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Green Cross
  • Developer GC Pharma
  • Class Iduronate sulfatases
  • Mechanism of Action Iduronate sulfatase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mucopolysaccharidosis II
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Mucopolysaccharidosis II

Most Recent Events

  • 25 Oct 2016 Phase-I/II clinical trials in Mucopolysaccharidosis II in Japan (Intracerebral)
  • 03 Feb 2016 Green Cross Corporation plans a phase II trial for Mucopolysaccharidosis-II in USA (NCT02663024)
  • 01 Sep 2013 Green Cross completes phase III trial for Mucopolysaccharidosis II (in children) in South Korea (NCT01645189)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top